Imagin Medical Secures New $3 Million Convertible Note Financing
August 26, 2021 16:56 ET
|
Imagin Medical Inc.
Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board.Imagin Medical’s i/Blue™ Imaging...
Imagin Medical on Schedule for American Urology Association Demonstration
August 17, 2021 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the...
IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS
March 16, 2021 08:05 ET
|
Imagin Medical Inc.
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”)...
IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING
February 18, 2021 08:30 ET
|
Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the...
Imagin Medical Engages Torrey Hills Capital
January 20, 2021 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to...
Imagin Medical Builds Momentum for 2021
January 13, 2021 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones...
Streetwise Reports Publishes 'Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery'
January 15, 2020 07:00 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Imagin Medical Inc. (IME:CSE; IMEXF:OTCQB) is developing technology that can greatly improve the ability to visualize cancer during minimally...